MENU
+Compare
PRVA
Stock ticker: NASDAQ
AS OF
Sep 18, 04:59 PM (EDT)
Price
$22.61
Change
+$0.40 (+1.80%)
Capitalization
2.77B

PRVA Privia Health Group Forecast, Technical & Fundamental Analysis

Privia Health Group Inc is a technology-driven, national physician-enablement company... Show more

PRVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRVA with price predictions
Sep 17, 2025

PRVA in upward trend: 10-day moving average moved above 50-day moving average on August 22, 2025

The 10-day moving average for PRVA crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

PRVA moved above its 50-day moving average on August 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRVA advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 186 cases where PRVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PRVA moved out of overbought territory on September 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PRVA as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PRVA turned negative on September 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRVA broke above its upper Bollinger Band on August 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.992) is normal, around the industry mean (20.379). PRVA has a moderately high P/E Ratio (202.000) as compared to the industry average of (82.138). PRVA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.776). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (1.485) is also within normal values, averaging (67.300).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PRVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRVA is expected to report earnings to rise 161.00% to 5 cents per share on November 06

Privia Health Group PRVA Stock Earnings Reports
Q3'25
Est.
$0.05
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.15
The last earnings report on August 07 showed earnings per share of 1 cents, missing the estimate of 5 cents. With 551.02K shares outstanding, the current market capitalization sits at 2.77B.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
950 North Glebe Road
Phone
+1 571 366-8850
Employees
1102
Web
https://www.priviahealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAGIX36.25N/A
N/A
Gabelli Global Rising Income and Div I
IHGIX36.34N/A
N/A
Hartford Dividend and Growth A
CISMX13.44N/A
N/A
Clarkston Partners Institutional
ACUSX13.81N/A
N/A
Advisors Capital Total Return – Equity
CEMVX14.27N/A
N/A
Causeway Emerging Markets Investor

PRVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRVA has been loosely correlated with CSGS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PRVA jumps, then CSGS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRVA
1D Price
Change %
PRVA100%
-0.45%
CSGS - PRVA
48%
Loosely correlated
+1.36%
RIOT - PRVA
46%
Loosely correlated
+0.57%
EVCM - PRVA
45%
Loosely correlated
+0.77%
EVTC - PRVA
45%
Loosely correlated
+0.81%
SPT - PRVA
45%
Loosely correlated
-0.21%
More

Groups containing PRVA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRVA
1D Price
Change %
PRVA100%
-0.45%
Health Services
category (437 stocks)
24%
Poorly correlated
+1.21%
Services to the Health Industry
category (95 stocks)
10%
Poorly correlated
+1.04%